Market Tracker

11/28 6:05pm ET

Northwest Biotherapeutics Inc (NASDAQ:NWBO)

5.36
Data as of Nov 28
 -0.04 / -0.74%
Today’s Change
3.20
Today|||52-Week Range
10.64
+42.18%
Year-to-Date
No recent news for Northwest Biotherapeutics Inc.

Today’s Trading

Previous close5.40
Today’s open5.50
Day’s range5.36 - 5.56
Volume223,591
Average volume (3 months)529,639
Market cap$336.0M
Dividend yield--
Data as of 12:59pm ET, 11/28/2014

Growth & Valuation

Earnings growth (last year)+65.03%
Earnings growth (this year)+8.50%
Earnings growth (next 5 years)+10.00%
Revenue growth (last year)+4.79%
P/E ratioNM
Price/Sales153.15
Price/Book--

Competitors

 Today’s
change
Today’s
% change
VTAEVitae Pharmaceutical...+1.59+8.48%
CORTCorcept Therapeutics...-0.12-3.81%
TKAITokai Pharmaceutical...+0.01+0.07%
XNCRXencor Inc+0.06+0.54%
Data as of 1:00pm ET, 11/28/2014

Financials

Last reporting dateNovember 14, 2014
EPS forecast (this quarter)-$0.33
Annual revenue (last year)$809.0K
Annual profit (last year)-$65.8M
Net profit margin-8,132.14%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman, President, CEO, CFO &
CAO
Linda F. Powers
Chief Scientific Officer, Secretary &
Director
Alton L. Boynton
Corporate headquarters
Bethesda, Maryland

Forecasts